Home

Search

Pathway AI

Account ⋅ Sign Out

Table of contents

Hip osteoarthritis

Key sources
The following summarized guidelines for the management of hip osteoarthritis are prepared by our editorial team based on guidelines from the American Academy of Family Physicians (AAFP 2024), the American Academy of Orthopaedic Surgeons (AAOS 2023), the American College of Rheumatology (ACR/AAHKS 2023), and the American College of Rheumatology (ACR 2020).
1
2
3
4

Guidelines

1.Medical management

Non-opioid analgesics
As per AAOS 2023 guidelines:
Offer oral NSAIDs to reduce pain and improve function in patients with symptomatic hip OA, unless contraindicated.
A
Consider offering oral acetaminophen to improve pain and function in patients with symptomatic hip OA, unless contraindicated.
E
Create free account

More topics in this section

  • Opioids

  • Duloxetine

  • Agents with no evidence for benefit

2.Nonpharmacologic interventions

Weight loss: advise losing weight in overweight and obese patients with hip OA.
A

More topics in this section

  • Physical therapy

  • Self-management programs

  • Walking canes

  • Footwear

  • CBT

  • Alternative and complementary therapies

3.Therapeutic procedures

Intra-articular corticosteroids: as per AAFP 2024 guidelines, consider administering intra-articular corticosteroid injections for the management of pain in patients with hip OA.
C
Show 2 more

More topics in this section

  • Other intra-articular injections

  • Transcutaneous electrical nerve stimulation

4.Perioperative care

Anesthesia: consider administering neuraxial anesthesia to reduce adverse events in patients undergoing total hip arthroplasty.
C

More topics in this section

  • Intraoperative tranexamic acid

  • Postoperative physical therapy

5.Surgical interventions

Total hip arthroplasty, timing: consider performing elective hip arthroplasty without delay, rather than delaying for 3 months,
C
or for a trial of physical therapy,
C
NSAIDs, intra-articular corticosteroid injections, viscosupplementation injections, or braces and/or ambulatory aids, in patients with radiographically moderate-to-severe OA with moderate-to-severe pain or loss of function eligible for elective total joint arthroplasty decided through a shared decision-making process and completed ≥ 1 trial of appropriate nonoperative therapy.
C
Show 4 more

More topics in this section

  • Total hip arthroplasty (prognostic factors)

  • Total hip arthroplasty (technical considerations)